AP2 Typhimurium

Lianglan Li1, Qiufen Mo2,3, Yi Wan2

  • 1Department of Critical Care Medicine, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.

BMC microbiology
|February 5, 2025
PubMed
概括

口服抗微生物AP2通过调节肠道微生物群组成来保护小鼠免受沙门氏菌Typhimurium感染. 这种疗法对抗细菌疾病和改善肠道健康充满希望.